BFG
GILD icon

Bleakley Financial Group’s Gilead Sciences GILD Stock Holding History

Bleakley Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69M Sell
29,179
-26,153
-47% -$3.45M 0.05% 309
2026
Q1 		$7.71M Buy
55,332
+24,649
+80% +$3.45M 0.12% 141
2025
Q4 		$3.77M Buy
30,683
+3,493
+13% +$424K 0.07% 229
2025
Q3 		$3.02M Sell
27,190
-254
-0.9% -$28.9K 0.07% 231
2025
Q2 		$3.04M Sell
27,444
-13,535
-33% -$1.44M 0.08% 223
2025
Q1 		$4.59M Buy
40,979
+15,495
+61% +$1.6M 0.15% 134
2024
Q4 		$2.35M Buy
25,484
+2,414
+10% +$217K 0.07% 227
2024
Q3 		$1.93M Buy
23,070
+1,947
+9% +$149K 0.06% 260
2024
Q2 		$1.45M Sell
21,123
-768
-4% -$51.3K 0.04% 334
2024
Q1 		$1.6M Buy
21,891
+10
+0% +$769 0.05% 330
2023
Q4 		$1.77M Buy
21,881
+1,869
+9% +$145K 0.06% 297
2023
Q3 		$1.5M Sell
20,012
-3,177
-14% -$244K 0.05% 310
2023
Q2 		$1.79M Sell
23,189
-1,451
-6% -$116K 0.06% 294
2023
Q1 		$2.04M Sell
24,640
-2,427
-9% -$201K 0.07% 250
2022
Q4 		$2.32M Buy
+27,067
New +$2.14M 0.08% 221

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bleakley Financial Group's GILD Position: Q2 2026 in Review

Bleakley Financial Group reduced its Gilead Sciences (GILD) stake by 47% in Q2 2026, selling an estimated $3.45M and leaving 29,179 shares worth $3.69M. The position accounts for 0.05% of the portfolio, ranked #309.

Bleakley Financial Group first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.71M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bleakley Financial Group held 29,179 shares of Gilead Sciences worth $3.69M as of Q2 2026.
  • Bleakley Financial Group sold 26,153 Gilead Sciences shares in Q2 2026, an estimated $3.45M.
  • Gilead Sciences made up 0.05% of Bleakley Financial Group's portfolio in Q2 2026, its #309 holding.
  • Bleakley Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Gilead Sciences position peaked at $7.71M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.